Back to Gene
KRT17 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

KRT17 gene

The KRT17 gene provides instructions for making keratin 17, a protein essential for the structural integrity of skin, hair, and nails.

Normal Function

The KRT17 gene provides instructions for making a protein called keratin 17 or K17. Keratins are a group of tough, fibrous proteins that form the structural framework of certain cells, particularly cells that make up the skin, hair, nails, and similar tissues. Keratin 17 is produced in the nails, the hair follicles, and the skin on the palms of the hands and soles of the feet. It is also found in the skin's sebaceous glands, which produce an oily substance called sebum that normally lubricates the skin and hair.

Keratin 17 partners with a similar protein, keratin 6b, to form molecules called keratin intermediate filaments. These filaments assemble into dense networks that provide strength and resilience to the skin, nails, and other tissues. Networks of keratin intermediate filaments protect these tissues from being damaged by friction and other everyday physical stresses. Keratin 17 is also among several keratins involved in wound healing.

Health Conditions Related to Genetic Changes

Pachyonychia congenita

More than 20 mutations in the KRT17 gene have been identified in people with pachyonychia congenita, a rare condition that primarily affects the nails and skin. In most cases, this condition becomes apparent within the first few months of life. Most of the KRT17 gene mutations associated with pachyonychia congenita change single protein building blocks (amino acids) in keratin 17.

The KRT17 gene mutations responsible for pachyonychia congenita change the structure of keratin 17, preventing it from interacting effectively with keratin 6b and interfering with the assembly of the keratin intermediate filament network. Without this network, skin cells become fragile and are easily damaged, making the skin less resistant to friction and minor trauma. Even normal activities such as walking can cause skin cells to break down, resulting in the formation of painful blisters and calluses. In the sebaceous glands, abnormal keratin filaments lead to the development of sebum-filled cysts called steatocystomas. Defective keratin 17 also disrupts the growth and function of other tissues, such as the hair follicles and nails.

Steatocystoma multiplex

At least four mutations in the KRT17 gene have been found to cause a skin disorder called hereditary steatocystoma multiplex. Researchers suggest that this condition may be a mild form (variant) of pachyonychia congenita. Like pachyonychia congenita, hereditary steatocystoma multiplex involves the development of multiple sebaceous gland cysts called steatocystomas. Most people with hereditary steatocystoma multiplex do not have the other features of pachyonychia congenita, although mild nail and dental abnormalities are possible.

The KRT17 gene mutations that cause hereditary steatocystoma multiplex change single amino acids in the keratin 17 protein, which interferes with the assembly of the keratin intermediate filament network. In the sebaceous glands, these keratin abnormalities lead to the development of steatocystomas.

Other Names for This Gene

  • CK-17
  • cytokeratin-17
  • K17
  • K1C17_HUMAN
  • keratin 17, type I
  • keratin, type I cytoskeletal 17
  • keratin-17

Frequently Asked Questions

Pachyonychia congenita often presents with thickened, painful nails (nail dystrophy), white or yellowish nail discoloration, and hyperkeratotic calluses on the palms and soles. Skin lesions may include painful cysts, cystic acne, or hyperkeratotic plaques, especially in the oral mucosa and genital area. How is a KRT17 mutation diagnosed in a suspected case of pachyonychia congenita?::A dermatologist will assess the characteristic nail and skin findings. Confirmation requires genetic testing—usually sequencing of the KRT17 gene—to detect pathogenic variants. What treatment options are available to manage the symptoms of pachyonychia congenita?::Management focuses on symptom relief: topical keratolytics (e.g., urea or salicylic acid) for calluses, oral retinoids for nail dystrophy, and pain control with topical anesthetics or oral analgesics. Regular nail care, avoiding trauma, and maintaining skin hydration can also help. Can pachyonychia congenita be passed on to children, and what are the chances?::Yes, it is usually autosomal dominant. If a parent carries a pathogenic KRT17 mutation, each child has a 50% chance of inheriting the condition. Genetic counseling can provide personalized risk assessment and family planning guidance.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA